Skip to main content
Figure 4 | Arthritis Research & Therapy

Figure 4

From: Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

Figure 4

Histological analysis of minor salivary gland biopsies in the rituximab and disease-modifying anti-rheumatic drug treatment groups. Histological analysis of minor salivary gland (MSG) biopsies in the rituximab (RTX) and disease-modifying anti-rheumatic drug (DMARD) treatment groups at baseline and week 120. 4×, 10×, 20× and 40×, level of magnification of the corresponding picture H&E, hematoxylin–eosin.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us